Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipients. [electronic resource]
- Transplantation Nov 2011
- 1063-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1534-6080
10.1097/TP.0b013e31822fa4b7 doi
Adolescent Adult Aged Antiviral Agents--therapeutic use Child Child, Preschool Cytomegalovirus--genetics Cytomegalovirus Infections--blood DNA, Viral--blood Female Ganciclovir--analogs & derivatives Humans Incidence Male Middle Aged Organ Transplantation Risk Factors Time Factors Treatment Outcome Valganciclovir Viral Load--methods Viremia--blood Young Adult